Cortexa

As Australia’s psychedelic program launches, PharmAla Biotech Holdings Inc.’s (OTC: PMBHF) new Aussie joint business Cortexa has executed its first purchase order for PharmAla’s GMP-compliant MDMA in both finished capsule and raw API forms. The MDXX-class molecules developer will...